Eva A. Temkin has joined Paul Hastings as chair of the FDA practice in Washington, D.C., the firm said Monday.
Temkin focuses her practice on regulatory, litigation, and transactional matters involving biomedical products regulated by the Food and Drug Administration, according to Paul Hastings.
She served as associate chief counsel at the FDA’s Office of Chief Counsel as well as director of policy for the Office of Therapeutic Biologics and Biosimilars. She joins the firm from King & Spalding.
This story was produced by Bloomberg Law Automation.
To contact Bloomberg Law Automation: automation@bloombergindustry.com
To contact the editors responsible for this story:
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.